methotrexate has been researched along with Vascular Calcification in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blegvad, J; Ellingsen, T; Hedemann-Nielsen, A; Herly, M; Kristensen, LD; Laurbjerg, TB; Løgstrup, BB; Masic, D; Urbonaviciene, G | 1 |
| Aslanidis, S; Doumas, M; Gavriilaki, E; Gkaliagkousi, E; Petidis, K; Stella, D | 1 |
1 review(s) available for methotrexate and Vascular Calcification
| Article | Year |
|---|---|
Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Autoimmune Diseases; Cardiovascular Diseases; Carotid Arteries; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Methotrexate; Pulse Wave Analysis; Regional Blood Flow; Risk Factors; Stem Cells; Tunica Intima; Tunica Media; Vascular Calcification; Vascular Stiffness; Vasodilation | 2012 |
1 other study(ies) available for methotrexate and Vascular Calcification
| Article | Year |
|---|---|
Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Denmark; Disease Progression; Echocardiography; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Tomography, X-Ray Computed; Vascular Calcification; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |